ForMyGluco
BlogGlossary← Home

Symptoms and diagnosis

How is diabetes caught before a complaint appears?

· 2 min

A water surface completely still on a windless morning; not one ripple, and the stones underneath sit blurred, impossible to make out.

Diabetes goes through a long stretch producing no complaint, and in it only a measurement makes the picture visible. So diagnosis often falls on the measurement’s turn, not the complaint’s. Guidelines bring up measuring in symptom-free adults because of this gap. Then what does shortening this wait change?

Feeling nothing is the hardest picture to describe. No pain, no thirst, no weight loss. Morning and evening, everything runs as always. When blood sugar starts climbing, the body produces no warning. All it produces is silence. That silence’s length is only estimated by going back.

That stretch has no direct measure. The starting day shows up in no record. One study took an indirect route. In two separate populations, a small-vessel finding’s frequency was plotted against time since diagnosis, and the line extended backward. The point where the finding hit zero fell years before diagnosis day.

Screening’s logic comes from this gap. If a complaint-free picture reaches measurement, a window exists where measurement comes before the complaint. One guideline’s criteria describe who comes first in that window by the weight of factors: excess weight, a family history alongside it, a history of diabetes in pregnancy, an earlier borderline result. The age threshold and repeat interval, though, are that same guideline’s own choices; their reasoning is the quiet period itself.

What screening asksIts diabetes counterpart
Is there a quiet period?There is; only backward estimation finds its start
Can it be measured in that period?It is; even in the complaint-free band, blood glucose becomes a number
What does finding it early change?The heading measured in one record was the death rate; no difference there

Behind that last row stands a single study. In a wide primary care network of high-risk adults, practices were split by lot: screening was done in some, not in others. The outcome variable, chosen up front, was the death rate. After nearly ten years of follow-up, the groups showed no difference. Not in overall death, not in heart-vessel deaths, not in diabetes-tied ones.

This result reads two ways, and one is wrong. The study measured that group screening of high-risk adults left the ten-year death rate unchanged. Most of the crowd screened had no diabetes anyway. The rate was figured over the whole crowd; the number diagnosed stayed small in the pool. In the study’s own reading, the gain looks limited to those whose illness could be found.

The post “Which lab tests are used to diagnose diabetes?” picks up from here. The post “What are the first signs of diabetes?” lists the signs that appear when the silence breaks. Prediabetes stays in that same quiet band too: a result short of the diagnosis threshold but above the usual range.

Two sentences are left, both from the same record. Group screening of high-risk adults did not move the ten-year death rate in the records. The second was never tested there: in someone with no complaint, diabetes shows only through a measurement.

Sources

  1. Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet. 2012;380(9855):1741-1748. doi:10.1016/S0140-6736(12)61422-6
  2. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15(7):815-819. doi:10.2337/diacare.15.7.815
  3. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27–S49. doi:10.2337/dc26-S002
  4. Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD). Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu-2026. 17. Baskı. TEMD; 2026. ISBN 978-625-99759-8-6

This piece is for information only; it is not a diagnosis, treatment or dosing recommendation. Always make decisions about your treatment together with your doctor.

Start keeping your own record

ForMyGluco keeps your readings, medications and appointments in one place, and prepares a doctor-ready PDF in a single tap.

View on the App Store →

All of the blog